Literature DB >> 12661039

Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancer.

Sabine Rohrmann1, William W Roberts, Patrick C Walsh, Elizabeth A Platz.   

Abstract

BACKGROUND: Little is known about predictors of prostate cancer severity in young men. Therefore, we examined whether family history and obesity influence risk of high-grade disease and extraprostatic extension in men < 55-years old.
METHODS: Four hundred ninety-eight men aged < 55 years who had had a radical prostatectomy (1992-1999) by one surgeon were mailed a survey in 2000 to assess family history of PCa and anthropometrics. Body mass index (BMI = kg/m(2)) was calculated as an indicator of obesity. Logistic regression was used to compute odds ratios (OR) for high-grade disease (Gleason score > or = 7) and extraprostatic extension.
RESULTS: Of the 363 respondents, 35.8% had at least one first-degree relative with PCa. Men with a family history were younger at surgery than those without a family history (48.8 vs. 50.1 years, P < 0.001). After controlling for age, cigarette smoking, and race/ethnicity, men with an affected father had a lower risk of high-grade disease compared to those without an affected father (OR = 0.42, 95% CI 0.23-0.76). Risk of high-grade disease increased with increasing BMI, especially in men < 50-years old (P-trend = 0.02). Family history and BMI were not clearly associated with extraprostatic extension.
CONCLUSIONS: After taking into account a younger age at presentation among men with a family history, young men with a family history of PCa were less likely to have high-grade disease. Obesity may be associated with a poorer histology in young men with PCa, especially in men younger than 50 years of age. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12661039     DOI: 10.1002/pros.10211

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  16 in total

1.  Examining the relationship between obesity and prostate cancer.

Authors:  Stephen J Freedland; William J Aronson
Journal:  Rev Urol       Date:  2004

2.  Leptin increases prostate cancer aggressiveness.

Authors:  Constanza M López Fontana; María E Maselli; Rafael F Pérez Elizalde; Nicolás A Di Milta Mónaco; Ana L Uvilla Recupero; José D López Laur
Journal:  J Physiol Biochem       Date:  2011-05-11       Impact factor: 4.158

3.  Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy.

Authors:  Kozhaya N Mallah; Christopher J DiBlasio; Audrey C Rhee; Peter T Scardino; Michael W Kattan
Journal:  Cancer       Date:  2005-05-15       Impact factor: 6.860

4.  Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer.

Authors:  Barbra A Dickerman; Thomas U Ahearn; Edward Giovannucci; Meir J Stampfer; Paul L Nguyen; Lorelei A Mucci; Kathryn M Wilson
Journal:  Int J Cancer       Date:  2017-06-08       Impact factor: 7.396

5.  [Association of a positive family history with histopathology and clinical course in early-onset prostate cancer].

Authors:  K Herkommer; T Paiss; M Merz; J E Gschwend; M Kron
Journal:  Urologe A       Date:  2006-12       Impact factor: 0.639

6.  Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era.

Authors:  Corinne E Joshu; Alison M Mondul; Andy Menke; Cari Meinhold; Misop Han; Elizabeth B Humphreys; Stephen J Freedland; Patrick C Walsh; Elizabeth A Platz
Journal:  Cancer Prev Res (Phila)       Date:  2011-02-16

Review 7.  Combination of physical activity, nutrition, or other metabolic factors and vaccine response.

Authors:  Kenneth W Hance; Connie J Rogers; Stephen D Hursting; John W Greiner
Journal:  Front Biosci       Date:  2007-09-01

8.  Impact of body mass index on outcomes after robot assisted radical prostatectomy.

Authors:  Erik P Castle; Fatih Atug; Michael Woods; Raju Thomas; Rodney Davis
Journal:  World J Urol       Date:  2007-10-17       Impact factor: 4.226

9.  Sequence variants of elaC homolog 2 (Escherichia coli) (ELAC2) gene and susceptibility to prostate cancer in the Health Professionals Follow-Up Study.

Authors:  Yen-Ching Chen; Edward Giovannucci; Peter Kraft; David J Hunter
Journal:  Carcinogenesis       Date:  2008-03-28       Impact factor: 4.944

10.  Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era.

Authors:  Yen-Ching Chen; John H Page; Rong Chen; Edward Giovannucci
Journal:  Prostate       Date:  2008-10-01       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.